SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $8,900,000 | -15.1% | 2,000,000 | -11.1% | 1.13% | -47.6% |
Q1 2017 | $10,485,000 | +1.3% | 2,250,000 | +32.4% | 2.16% | -11.6% |
Q4 2016 | $10,353,000 | +51.5% | 1,700,000 | +37.1% | 2.45% | +11.7% |
Q3 2016 | $6,832,000 | +35.2% | 1,240,000 | -6.8% | 2.19% | +13.9% |
Q2 2016 | $5,054,000 | -16.8% | 1,330,000 | -39.5% | 1.92% | -19.3% |
Q1 2016 | $6,072,000 | – | 2,200,000 | – | 2.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |